Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2009, Article ID 831626, 9 pages
http://dx.doi.org/10.1155/2009/831626
Research Article

Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy

1Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany
2Department of Internal Medicine II, University of Würzburg, 97080 Würzburg, Germany
3Department of Surgery, University of Würzburg, 97080 Würzburg, Germany
4Institute of Pathology, Ostalb-Klinikum Aalen, 73430 Aalen, Germany
5Department of Internal Medicine , Ostalb-Klinikum Aalen, 73430 Aalen, Germany

Received 30 August 2009; Revised 9 November 2009; Accepted 31 December 2009

Academic Editor: Francis Seow-Choen

Copyright © 2009 S. Gattenlöhner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

S. Gattenlöhner, B. Etschmann, V. Kunzmann, et al., “Concordance of KRAS/BRAF Mutation Status in Metastatic Colorectal Cancer before and after Anti-EGFR Therapy,” Journal of Oncology, vol. 2009, Article ID 831626, 9 pages, 2009. https://doi.org/10.1155/2009/831626.